Correct usage and dosage of Acalabrutinib, and how to use it?

Acalabrutinib) is a Brutontyrosine kinase inhibitor. Acalabrutinib is currently indicated for the treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy. Acalabrutinib is also approved for chronic lymphocytic leukemia and small lymphocytic lymphoma.

The recommended dose of acalabrutinib is 100 milligrams taken orally approximately every 12 hours, swallowed whole with water, before or after meals. Advise patients not to break, open, or chew capsules and to manage toxicity by interrupting treatment, reducing dose, or discontinuing treatment. Follow all directions on your prescription label, and read any medication guides or inserts. Your doctor may occasionally change the dose, take the medication exactly as directed.

If a patient needs surgery, tell the surgeon in advance that you are using acalabrutinib. You may need to stop taking the medicine for a short time. While using acalabrutinib, patients may need frequent blood tests. If you have had hepatitis B, it may come back and while you are using this drug. Patients may need liver function tests. Store medicationat room temperature, away from moisture and heat. If you miss a dose, take it as soon as possible, but if you take it more than 3 hours late, skip the missed dose and do not take two doses at once. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.